Angiotensin-converting enzyme gene polymorphism in overweight and obese Turkish patients with insulin resistance

DNA and Cell Biology

Volumn 29, Issue 4, 2010, Pages 207-212

  Akin, Fulya ^a   Turgut, Sebahat ^a   Bastemir, Mehmet ^a   Turgut, Gunfer ^a   Kursunluoglu, Raziye ^a   Karasu, Ugur ^a   Guclu, Aydin ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ACE PROTEIN, HUMAN; INSULIN; LIPID; URIC ACID;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE IDENTIFICATION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; TURKEY (REPUBLIC); ADIPOSE TISSUE; BLOOD; BLOOD PRESSURE; BODY MASS; GENETICS; GLUCOSE BLOOD LEVEL; HISTOLOGY; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; TURKEY; URIC ACID; WAIST CIRCUMFERENCE;

EID: 77951241845     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2009.0934     Document Type: Article

References (31)

1. Abuissa, H., Jones, P.G., Marso, S.P., and O'Keefe, J.H., Jr. (2005). Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 46, 821-826.
2. Araz, M.,Yilmaz, N., Güngör, K., Okan, V., Kepekci, Y., and Aynacioglu, A.S. (2001). Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients. Diabetes Res Clin Pract 54, 95-104.
3. Berntorp, K., Lindgärde, F., and Mattiasson, I. (1992). Long-term effects on insulin sensitivity and sodium transport in glucose-intolerant hypertensive subjects when β-blockade is replaced by captopril treatment. J Hum Hypertens 6, 291-298.
4. Bonnet, F., Patel, S., Laville, M., Balkau, B., Favuzzi, A., Monti, L.D., Lalic, N., and Walker M; European Group for the Study of Insulin Resistance Relationship Between Insulin Sensitivity and Cardiovascular Disease Risk Study Group. (2008). Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. Diabetes Care 31, 789-794.
5. Buchanan, T.A., Thawani, H., Kades, W., Modrall, J.G., Weaver, F.A., Laurel, C., Poppiti, R., Xiang, A., and Hsueh, W. (1993). Angiotensin II increases glucose utilization during acute hy- perinsulinemia via a hemodynamic mechanism. J Clin Invest 92, 720-726.
6. Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J.P., Arveiler, D., Luc, G., Bard, J.M., Bara, L., Ricard, S., Tiret, L., Amouyel, P., Alhenc-Gelas, F., and Soubrier, F. (1992). Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359, 641-644.
7. Engeli, S., Negrel, R., and Sharma, A.M. (2000). Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 35, 1270-1277.
8. Faloia, E., Giacchetti, G., and Mantero, F. (2000). Obesity and hypertension. J Endocrinol Invest 23, 54-62.
9. Giacchetti, G., Faloia, E., Mariniello, B., Sardu, C., Gatti, C., Camilloni, M.A., Guerrieri, M., and Mantero, F. (2002). Over-expression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens 15, 381-388.
10. Giacchetti, G., Faloia, E., Sardu, C., Camilloni, M.A., Mariniello, B., Gatti, C., Garrapa, G.G., Guerrieri, M., and Mantero, F. (2000). Gene expression of angiotensinogen in adipose tissue of obese patients. Int J Obes Relat Metab Disord 24, 142-143.
11. Huang, X.H., Rantalaiho, V., Wirta, O., Pasternack, A., Koivula, T., Hiltunen, T., Nikkari, T., and Lehtimaki, T. (1998). Relationship of the angiotensin-converting enzyme gene polymorphism to glucose intolerance, insulin resistance, and hypertension in NIDDM. Hum Genet 102, 372-378.
12. Karlsson, C., Lindell, K., Ottosson, M., Sjostrom, L., Carlsson, B., and Carlsson, L.M. (1998). Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab 83, 3925-3929.
13. Katsuya, T., Horiuchi, M., Chen, Y.D., Koike, G., Pratt, R.E., Dzau, V.J., and Reaven, G.M. (1995). Relations between deletion polymorphism of the angiotensin-converting enzyme gene and insulin resistance, glucose intolerance, hyperinsulinemia, and dyslipidemia. Arterioscler Thromb Vasc Biol 15, 779-782.
14. Lebovitz, H.E. (2002). Insulin resistance and the insulin resistance syndrome. In Clinician's Manual on Insulin Resistance, H.E. Lebovitz, ed. (Science Press, London), pp. 1-15.
15. Lee, Y.J., and Tsai, J.C. (2002). ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 25, 1002-1008.
16. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., and Turner, R.C. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
17. Nagi, D.K., Foy, C.A., Mohamed-Ali, V., Yudkin, J.S., Grant, P.J., and Knowler, W.C. (1998). Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery diseasein Pima Indians. Metabolism 47, 622-626.
18. NCEP ATPIII Guidelines (2001). Executive summary of the third report of the National Cholesterol Education Program NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Treatment Panel III. JAMA 285, 2486-2497.
19. Panahloo, A., Andres, C., Mohamed-Ali, V., Gould, M.M., Talmud, P., Humphries, S.E., and Yudkin, J.S. (1995). The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Circulation 15, 3390-3393.
20. Perticone, F., Ceravolo, R., Iacopino, S., Cloro, C., Ventura, G., Maio, R., Gulletta, E., Perotti, N., and Mattioli, P.L. (2001). Relationship between angiotensin-converting enzyme gene polymorphism and insulin resistance in never-treated hypertensive patients. J Clin Endocrinol Metab 86, 172-178.
21. Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., and Soubrier, F. (1990). An insertion/deletion polymorphism in the angiotensin I converting gene accounting for half the variance of serum enzyme levels. J Clin Invest 86, 1343-1346.
22. Ruiz, J., Blanché, H., Cohen, N., Velho, G., Cambien, F., Cohen, D., Passa, P., and Froguel, P. (1994). Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin dependent diabetes mellitus. Proc Natl Acad Sci USA 91, 3662-3665.
23. Ryan, A.S., Nicklas, B.J., Berman, D.M., and Ferrell, R.E. (2001). The insertion/deletion polymorphism of teh ACE gene is related to insulin sensitivity in overweight women. Diabetes Care 24, 1646-1652.
24. Takezako, T., Saku, K., Zhang, B., Ou, J., Bai, H., Imai, K., Jimi, S., Shirai, K., and Arakawa, K. (1999). Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with angina pectoris. Am J Hypertens 12, 291-297.
25. Tanrverdi, H., Evrengül, H., Tanrverdi, S., Turgut, S., Akdag, B., Kaftan, H.A., and Semiz, E. (2005). Improved endothelium dependent vasodilation in endurance athletes and its relation with ACE I/D polymorphism. Circ J 69, 1105-1110.
26. Tiret, L., Rigat, B., Visvikis, S., Breda, C., Corvol, P., Cambien, F., and Soubrier, F. (1992). Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51, 197-205.
27. Turgut, G., Turgut, S., Genç, O., Atalay, A., and Atalay, E.Ö. (2004). The angiotensin converting enzyme I/D polymorphism in Turkish athletes and sedentary controls. Acta Med 47, 133-136.
28. Umemura, S., Nyui, N., Tamura, K., Hibi, K., Yamaguchi, S., Nakamaru, M., Ishigami, T., Yabana, M., Kihara, M., Inoue, S., and Ishii, M. (1997). Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 10, 629-633.
29. Viitanen, L., Pihlajamaki, J., Halonen, P., Lehtonen, M., Kareinen, A., Lehto, S., and Laakso, M. (2001). Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease. Atherosclerosis 157, 57-64.
30. Yang, M., Qiu, C.C., Xu, O., and Xiang, H.D. (2006). Association of angiotensin converting enzyme gene I/D polymorphism with type 2 diabetes mellitus. Biomed Environ Sci 19, 323-327.
31. Zingone, A., Dominijanni, A., Mele, E., Marasco, O., Melina, F., Minchella, P., Quaresima, B., Tiano, M.T., Gnasso, A., and Pujia, A. (1994). Deletion polymorphism in the gene for angiotensin converting enzyme is associated with elevated fasting blood glucose levels. Hum Genet 94, 207-209.